Two Hub Resident Clients Make Final Four at BioFlorida Pitch Competition (BioFlorida)

Hundreds of Florida’s executives, scientists, researchers, investors, legislators, and service providers from the biopharmaceutical, medical device, and healthIT gathered at the BioFlorida Annual Conference to hear from experts on recent industry trends, connect with investors and potential partners, celebrate Florida innovation and achievements, and continue the growth of the industry.

Seed and early-stage companies participated in the BioPitch competition, which provided opportunities for coaching, as well as presentations to investors for feedback and potential funding. The four semi-finalists included HealthSteps (UF Innovate | The Hub resident client in Gainesville), KynderMed (Tallahassee), Antibiotic Adjuvant (also from UF Innovate | The Hub in Gainesville), and STAT3 Therapeutics (Coral Springs)- with STAT3 Therapeutics (Coral Springs), a company taking a unique approach to develop and commercialize drugs that target the activated STAT3 molecule in a specific and impactful way without significant toxic side effects, winning the top recognition.

Learn more about Two Hub Resident Clients Make Final Four at BioFlorida Pitch Competition.